🔎 Trials Near Me

Domov › Rakovina prostaty › Vermont

Klinické štúdie Rakovina prostaty v štáte Vermont

5 štúdií pre Rakovina prostaty hľadá účastníkov v zariadeniach v štáte Vermont.

Mestá v štáte Vermont

Oficiálny text štúdie (anglicky)

Testing the Addition of Docetaxel (Chemotherapy) to the Usual Treatment (Hormonal Therapy and Apalutamide) for Metastatic Prostate Cancer, ASPIRE Trial

  • Central Vermont Medical Center/National Life Cancer Treatment, Berlin Corners
  • University of Vermont Medical Center, Burlington
  • University of Vermont and State Agricultural College, Burlington
Prebieha náborFáza 3
Vek 18 a viac · Muži · Aktualizované 2. 10. 2026 · NCT06931340

Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer

  • Central Vermont Medical Center/National Life Cancer Treatment, Berlin Corners
  • University of Vermont Medical Center, Burlington
  • University of Vermont and State Agricultural College, Burlington
  • a 1 ďalších
Prebieha náborFáza 3
Vek 18 a viac · Muži · Aktualizované 10. 9. 2026 · NCT05946213

Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response

  • Dartmouth Cancer Center - North, Saint Johnsbury
Prebieha náborFáza 3
Vek 18 a viac · Muži · Aktualizované 14. 7. 2026 · NCT06592924

Fezolinetant for Treating Hot Flashes in Men With Prostate Cancer

  • University of Vermont Medical Center, Burlington
Prebieha náborFáza 2
Vek 18 a viac · Muži · Aktualizované 5. 2. 2026 · NCT06972875

Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer

  • Central Vermont Medical Center/National Life Cancer Treatment, Berlin Corners
  • University of Vermont Medical Center, Burlington
Prebieha náborFáza 3
Vek 18 a viac · Muži · Aktualizované 11. 9. 2025 · NCT03678025

Z ClinicalTrials.gov, dáta načítané 5. 10. 2026. Každá štúdia má vlastné kritériá oprávnenosti; tím štúdie rozhoduje o účasti.